This week on the Joint Action podcast, we’re joined by Professor Henning Bliddal, a leading researcher and Director at the Parker Institute in Denmark. Henning Bliddal has spent his career helping people with osteoarthritis live better lives.

In this episode, we talk about a breakthrough study using a medication called Semaglutide. This drug, originally made to help with weight loss, has shown amazing results in easing pain and improving movement for people with knee osteoarthritis. Henning explains how weight loss can take the pressure off your joints and why this is so important for managing knee osteoarthritis.

We cover:

• How Semaglutide works and why it helps with knee pain.
• The impressive results of the study, including big improvements in pain and function.
• Practical tips for staying active and managing weight to reduce joint stress.
• What we still need to learn about maintaining long-term benefits.

If you’re curious about the latest in osteoarthritis research and want practical tips for managing symptoms, join us on this week's episode.

RESOURCES

Have a question about osteoarthritis that you'd like answered? Send your question to osteoarthritis.research@sydney.edu.au by 16th December 2024 for a chance to have it featured in the final episode for 2024.

Articles

• Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis 

CONNECT WITH US

• Twitter: @ProfDavidHunter @jointactionorg
• Instagram: @osteoarthritisresearchgroup
• Email: osteoarthritis.research@sydney.edu.au
• Website: www.jointaction.info/podcast

Hosted on Acast. See acast.com/privacy for more information.